and Grubbs9g have described chiral 1,3-dialkyl-4,5-dihy-
droimidazol-2-ylidene complexes of Rh and Ru. Hydrosilyla-
tion9b and Heck reactions9d conducted with some of these
complexes have given only marginal asymmetric induction.
Since it is well-known that bidentate bisphosphine complexes
generally give much superior asymmetric induction in many
reactions vis-a´-vis the corresponding monodentate phosphine
complexes, we wondered whether a similar structural motif
could be constructed with chelating bis-carbenes.10 We have
recently completed a study of the synthesis, structure, and
reactivity of a new diimidazolin-2-ylidene ligand with a 2,2′-
binaphthyl backbone.11 In this paper we report the synthesis
and potential utility of novel chiral, chelated bis-carbene
complexes of palladium and nickel (1 and 2, eq 1) prepared
with this ligand.
organometallic carbene complexes (eq 1). (1) In situ forma-
tion of the ligand by reaction with a metal salt (MX) where
the X- counterion of the salt functions as the base required
for the carbene formation. (2) A two-step process where a
solution of the putative bis-carbene of the ligand was
generated under basic conditions and subsequently reacted
with the metal salt.
The reaction of Pd(OAc)2 with imidazolium salt 7 in
DMSO at 140 °C gave both the trans and the cis Pd
complexes 1a and 1b as yellow solids in 41% and 33% yields
after chromatography.14 The X-ray crystal structure analysis
confirmed the geometry of these Pd complexes (vide infra).
The absence of the signal for the imidazolium C-2 methine
protons in the 1H NMR spectra of the cis and trans
complexes indicated successful transformation of the salt into
the carbene. The NMR spectra indicated that the trans
complex was C2-symmetric, while the cis Pd complex 1b
had a more complex structure.13 A single downfield signal
in the 13C spectrum of 1a at 170.95 ppm for C-2 of the
imidazole moieties was present for the carbene carbons. The
(9) (a) Coleman, A. W.; Hitchcock, P. B.; Lappert, M. F.; Maskell, R.
K.; Mu¨ller, J. H. J. Organomet. Chem. 1983, 250, C9. (b) Herrmann, W.
A.; Goossen, L. J.; Ko¨cher, C.; Artus, G. R. J. Angew. Chem., Int. Ed.
Engl. 1996, 35, 2805. (c) Herrmann, W. A.; Goossen, L. J.; Artus, G. R. J.;
Ko¨cher, C. Organometallics 1997, 16, 2472. (d) Enders, D.; Gielen, H.;
Raabe, G.; Runsink, J.; Teles, J. H. Chem. Ber. 1996, 129, 1483. (e) Enders,
D.; Gielen, H.; Raabe, G.; Runsink, J.; Teles, J. H. Chem. Ber. 1997, 130,
1253. (f) Herrmann, W. A.; Goossen, L. J.; Spiegler, M. Organometallics
1998, 17, 2162. (g) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org.
Lett. 1999, 1, 953. (h) Other axial-chiral metal carbenes: Do¨tz, K. H.;
Tomuschat, P.; Nieger, M. Chem. Ber. 1997, 130, 1605.
The preparation of the ligand began with the reaction of
enantiomerically pure (S)-1,1′-bi-2-naphthol bis(trifluo-
romethanesulfonate) (3) with a solution of methylmagnesium
bromide under (dppp)NiCl2-catalyzed Kumada coupling
conditions to give dimethyl compound 4 (Scheme 1).12
(10) All chelated carbene complexes prepared previously have an N,N′-
methylene link between the imidazolines. Attempts to prepare other bridged
N,N′-complexes (C2, C3, C4, and o-xylylene) have not been successful. See
ref 8b.
(11) This work was presented by D.S.C. at the 218th National Meeting
of the American Chemical Society (New Orleans, August 1999), Paper
ORGN 167.
(12) (a) Kurz, L.; Lee, G.; Morgans, D. Jr.; Waldyke, M. J.; Ward, T.
Tetrahedron Lett. 1990, 31, 6324. (b) Uozumi, Y.; Tanahashi, A.; Lee, S.-
Y.; Hayashi, T. J. Org. Chem. 1993, 58, 1945. (c) Sengupta, S.; Leite, M.;
Raslan, D. S.; Quesnelle, C.; Snieckus, V. J. Org. Chem. 1992, 57, 4066.
(13) See Supporting Information for details.
Scheme 1. Synthesis of Diimidazolium Salts
(14) 1a and 1b: imidazolium salt 7 (358 mg, 0.512 mmol) and palladium
acetate (125 mg, 0.559 mmol) were stirred in DMSO (30 mL) at 140 °C
for 6 h. The solvent was removed by distillation under high vacuum, and
the residue was dissolved in CH2Cl2. Chromatography of the residue with
CH2Cl2 as eluant gave complex 1a (167 mg, 41%), and with ethyl acetate
gave complex 1b (135 mg, 33%) both as yellow solids. 1a: 1H NMR (300
MHz, CDCl3) δ 7.97 (d, J ) 7.8 Hz, 2H), 7.94 (d, J ) 7.5 Hz, 2H), 7.48
(dd, J ) 7.3, 7.5 Hz, 2H), 7.36 (dd, J ) 7.3, 8.7 Hz, 2H), 7.29 (d, J ) 8.7
Hz, 2H), 7.28 (d, J ) 7.8 Hz, 2H), 7.17 (d, J ) 1.8 Hz, 2H), 6.90 (d, J )
1.8 Hz, 2H), 5.70 (d, J ) 16.5 Hz, 2H), 4.70 (d, J ) 16.5 Hz, 2H), 3.81 (s,
6H); 13C NMR (75.469 MHz, CDCl3) δ 170.95 (2), 133.72 (2), 133.43 (2),
132.92 (2), 132.71 (2), 129.00 (2), 128.86 (2), 126.92 (2), 126.01 (2), 125.93
(2), 125.38 (2), 123.71 (2), 121.61 (2), 53.37 (2), 38.60 (2); MSFAB (SIMS-
(+)) m/z (relative intensity) 803 (C30H26N4PdI2, M+ + 1, 42), 802 (M+,
26), 675 (100); rev. phase HPLC (10% water in methanol, 1 mL/min, Zorbax
ODS, 300 nm) 3.87 min (100%). 1b: 1H NMR (300 MHz, CDCl3) δ 8.11
(d, J ) 8.7 Hz, 1H), 7.97 (d, J ) 8.4 Hz, 1H), 7.89 (d, J ) 7.5 Hz, 1H),
7.87 (d, J ) 8.4 Hz, 1H), 7.61 (d, J ) 8.7 Hz, 1H), 7.51 (dd, J ) 7.5, 7.5
Hz, 1H), 7.47 (dd, J ) 7.8, 8.4 Hz, 1H), 7.35 (d, J ) 1.8 Hz, 1H), 7.30-
7.35 (m, 2H), 7.22 (dd, J ) 7.8, 8.7 Hz, 1H), 7.10 (d, J ) 8.4 Hz, 1H),
6.98 (d, J ) 1.8 Hz, 1H), 6.80 (d, J ) 8.7 Hz, 1H), 6.41 (d, J ) 1.8 Hz,
1H), 5.98 (d, J ) 1.8 Hz, 1H), 5.80 (d, J ) 17.1 Hz, 1H), 5.71 (d, J ) 15.6
Hz, 1H), 4.87 (d, J ) 17.1 Hz, 1H), 4.69 (d, J ) 15.6 Hz, 1H), 3.89 (s,
3H), 3.73 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 164.21, 163.71, 134.03,
133.18, 133.08 (2), 133.02, 131.91, 131.44, 130.78, 129.91, 128.86, 128.77,
128.21, 127.47, 126.93, 126.65, 126.30, 126.14, 125.20, 124.28, 124.01,
123.34, 122.60, 121.27, 113.15, 55.31, 52.89, 39.58, 39.52; MSFAB (SIMS-
(+)) m/z (relative intensity) 803 (C30H26N4PdI2, M+ + 1, 6), 802 (M+,
12), 675 (100); rev. phase HPLC (10% water in methanol, 1 mL/min, Zorbax
ODS, 300 nm) 3.83 min (100%).
Photolysis in carbon tetrachloride with N-bromosuccinimide
gave dibromomethyl compound 5. Bis-alkylation with the
anion of imidazole followed by quaternization of the imi-
dazole ring at the 3-position with methyl iodide completed
the synthesis of the desired diimidazolium salt 7 in an overall
yield of greater than 65% for the four steps.13
A variety of conditions, which can be grouped into two
main categories,3 were examined for the preparation of the
1126
Org. Lett., Vol. 2, No. 8, 2000